MAYRA VALDEZ: Open Payments
NPI 1003447863 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 9 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $268 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $162 |
| Novo Nordisk Inc | 1 | $102 |
| Saluda Medical Americas, Inc. | 2 | $44 |
| Veloxis Pharmaceuticals, Inc. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| One Lambda, Inc. | 1 | $16 |
Products named: LIVTENCITY, Rivfloza, Evoke, ENVARSUS, XIFAXAN.
Industry payments across TX — which companies pay providers there.
